DEUTSCHE BANK AG\

Bank

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M

Back to ALNY Full portfolio

Position in ALNY

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$245,459,858

-$6,485,732 QoQ

Shares Held

815,400

+7.1% QoQ

Ownership

0.609%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#30

of 780 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 47% Shared 0% None 53%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Derivatives in ALNY

reported options exposure · as of Jun 30, 2026

CallValue

CallShares

PutValue

$3,130,712

PutShares

10,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. ALNY ranks #3 (7.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,579,110	$784,391,303
2	REGN	Regeneron Pharmaceuticals, Inc.	518,409	$323,248,743
3	ALNY	Alnylam Pharmaceuticals, Inc. This page	815,400	$245,459,858
4	RVMD	Revolution Medicines, Inc.	888,019	$166,308,196
5	RPRX	Royalty Pharma plc	2,717,951	$152,395,510
6	INCY	Incyte Corp	1,262,988	$143,172,312
7	ARGX	Argenx SE	137,335	$127,415,291
8	LGND	Ligand Pharmaceuticals Inc	249,611	$78,899,539

All Filings in ALNY

Export CSV

36 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$245,459,858	815,400	+7.1%	Shares	Sole	2026-08-07
2026-06-30	$3,130,712	10,400	0.0%	Put	Sole	2026-08-07
2026-03-31	$3,441,048	10,400	0.0%	Put	Sole	2026-05-06
2026-03-31	$251,945,590	761,464	+7.0%	Shares	Sole	2026-05-06
2025-12-31	$283,116,855	711,975	+17.4%	Shares	Sole	2026-02-11
2025-12-31	$4,135,560	10,400	+26.8%	Put	Sole	2026-02-11
2025-09-30	$3,739,200	8,200	-5.7%	Put	Sole	2025-11-13
2025-09-30	$276,481,920	606,320	-6.6%	Shares	Sole	2025-11-13
2025-06-30	$211,725,016	649,284	+12.5%	Shares	Defined	2025-08-12
2025-03-31	$155,799,647	576,993	+3.7%	Shares	Sole	2025-05-09
2024-12-31	$752,992	3,200	-93.6%	Call	Sole	2025-06-30
2024-12-31	$130,968,601	556,579	+3.2%	Shares	Sole	2025-06-30
2024-09-30	$148,315,700	539,271	+10.3%	Shares	Sole	2025-06-26
2024-06-30	$2,114,100	8,700	—	Put	Sole	2025-06-12
2024-06-30	$118,855,674	489,118	-3.5%	Shares	Sole	2025-06-12
2024-06-30	$12,198,600	50,200	+195.3%	Call	Sole	2025-06-12
2024-03-31	$75,782,655	507,077	+9.7%	Shares	Sole	2025-06-02
2024-03-31	$2,540,650	17,000	-4.5%	Call	Sole	2025-06-02
2023-12-31	$3,407,098	17,800	+35500.0%	Call	Sole	2024-02-14
2023-12-31	$88,492,476	462,319	-0.1%	Shares	Sole	2024-02-14
2023-09-30	$81,971,795	462,856	-4.9%	Shares	Sole	2023-11-24
2023-06-30	$92,477,225	486,876	+5.9%	Shares	Defined	2023-08-14
2023-03-31	$10,016	50	—	Call	Defined	2023-05-15
2023-03-31	$92,060,257	459,566	-1.2%	Shares	Defined	2023-05-15
2022-12-31	$110,519,843	465,053	+83.3%	Shares	Defined	2023-02-13
2022-09-30	$50,777,388	253,684	+2.6%	Shares	Defined	2022-11-14
2022-06-30	$36,060,973	247,247	-12.4%	Shares	Defined	2022-08-11
2022-03-31	$46,065,739	282,110	+2.7%	Shares	Defined	2022-05-13
2021-12-31	$46,574,805	274,648	-2.7%	Shares	Defined	2022-02-16
2021-09-30	$53,275,006	282,162	+6.5%	Shares	Defined	2021-11-04
2021-06-30	$44,896,183	264,843	+2.4%	Shares	Defined	2021-08-11
2021-03-31	$36,509,190	258,582	-11.8%	Shares	Defined	2021-05-13
2020-12-31	$38,115,910	293,267	+2.0%	Shares	Defined	2021-02-16
2020-09-30	$41,860,872	287,506	+0.5%	Shares	Defined	2020-11-12
2020-06-30	$42,372,788	286,090	-2.2%	Shares	Defined	2020-08-13
2020-03-31	$31,854,187	292,643	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.